ArticleScientific reports2022

Innovative targets of the lncRNA-miR-mRNA network in response to low-dose aspirin in breast cancer patients.

Sadaf Alipour et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.